Aptol Pharma
Aptol Pharma is a biotechnology platform company which aims to develop first-in-class functional cures for a broad range of autoimmune diseases via our proprietary peptide-nanoparticle technology. Four founders of the company together with our BoD strive to make our first asset APT001 for rheumatoid arthritis Phase 1 ready in 2025: Founders: Kira Astakhova: Ass. Professor at DTU, Expert in the aptamer technology development Mads Clausen - Professor at DTU and expert in bioorganic chemistry Tue Wenzel Kragstrup - Rheumatology specialist, Clinician Mark Daniel Zalomajev - marketing and business developer BoD: Anders Dyhr Dombernowsky-Toft (Exec. Chairman) Nicolai Wagtmann"
7-day free trial · no credit card
Verified contacts
1
available on Kipplo
LinkedIn employees
5
1 to 10 range
Open roles
—
no listings
Distinct roles
1
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 1 verified contacts at Aptol Pharma
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
1 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Top roles at Aptol Pharma
1 distinct titles indexed · top 1 shown.
- 1founder and scientific advisor
Sign up to unlock all 1 contacts at Aptol Pharma
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 1 verified contacts at Aptol Pharma
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.